tirzepatide dual is a GLP-1 and GIP receptor agonist shown to drive profound weight loss, improve insulin sensitivity, and reduce cardiometabolic risk. Beyond fat loss, its indirect benefits may support mitochondrial efficiency Physical Health High heart rate after Pre-Filled Pen:0.25 mg

tirzepatide dual is a GLP-1 and GIP receptor agonist shown to drive profound weight loss, improve insulin sensitivity, and reduce cardiometabolic risk. Beyond fat loss, its indirect benefits may support mitochondrial efficiency Physical Health High heart rate after Pre-Filled Pen:0.25 mg

High heart rate after starting Ozempic for weight loss

(Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced a new, lower cash-pay price for GLP-1 medications, Wegovy ® and Ozempic ® , made possible through its ongoing collaboration with Novo Nordisk

Physical Health

Pre-Filled Pen:0.25 mg

The FDA and the American College of Obstetricians and Gynecologists (ACOG) advise against using GLP-1 medications during pregnancy